ABBV

AbbVie Inc. Common Stock NYSE

Last close $244.46 as of 07 Aug 2026

Avg call return: +2.2%
Scored calls: 8
Channels: 7
Win Rate: 50%
Side taken: 8Buy 0Sell

8 scored calls · 7 channels · first tracked 25 Dec 2025

Who is calling ABBV

Last 12 months · 7 buying · 0 selling

01 Mark Roussin, CPA Buy Calls 2 Return +14.8% Show calls
1. 05 May 2026 Buy Entry $206.11 Now $244.46 +18.6%
  I believe the $200 level or less is a compelling entry point for this great company.
2. 10 Jan 2026 Buy Entry $220.08 Now $244.46 +11.1%
  stock number seven, which is going to be AVY, stock ticker ABBV... Analysts are still upbeat on the stock, rating it a buy
Full record for Mark Roussin, CPA
02 MarketBeat Buy Calls 1 Return +6.3% Show calls
1. 25 Dec 2025 Buy Entry $229.89 Now $244.46 +6.3%
  Abby is a buy and hold. It's a it's it's a must own buy and hold stock.
Full record for MarketBeat
03 CNBC Television Buy Calls 1 Return +0.1% Show calls
1. 15 Jul 2026 Buy Entry $244.22 Now $244.46 +0.1%
  Abby is doing fabulously. I want you to buy it.
Full record for CNBC Television
04 TheStreet Buy Calls 1 Return −1.4% Show calls
1. 13 Jul 2026 Buy Entry $248.00 Now $244.46 −1.4%
  but so is AbbVie.
Full record for TheStreet
05 Blue Cloud Trading Buy Calls 1 Return −5.7% Show calls
1. 24 Jul 2026 Buy Entry $259.29 Now $244.46 −5.7%
  This is an absolute ad right now at 15 times earnings, 3% dividend yield.
Full record for Blue Cloud Trading
06 Dividend Talks Buy Calls 1 Return −5.7% Show calls
1. 26 Jul 2026 Buy Entry $259.36 Now $244.46 −5.7%
  a very respectable buy rating from Wall Street.
Full record for Dividend Talks
07 Let's Talk Money! with Joseph Hogue, CFA Buy Calls 1 Return −5.7% Show calls
1. 26 Jul 2026 Buy Entry $259.36 Now $244.46 −5.7%
  drug maker AbbVie ticker ABBV which trades for 18 times earnings even after it's 35% run.
Full record for Let's Talk Money! with Joseph Hogue, CFA